HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 µM and 1.15 µM, respectively. Moreover, HBV-IN-25 demonstrates favorable aqueous solubility (LYSA>452 µg/mL) and no cellular toxicity, making it a promising candidate for further investigation and development [1].
Molecular Weight:
343.76
CAS Number:
[2161364-69-6]
Formula:
C18H14ClNO4
Target:
Others|||HBV
T61115
* VAT and and shipping costs not included. Errors and price changes excepted
